Cognard V型硬脑膜动静脉瘘的多中心CONDOR登记研究
基于CONDOR多中心登记(16家学术中心),回顾性分析1077例硬脑膜动静脉瘘中37例(3%)Cognard V型病变。患者平均57岁,59.5%为男性,68%表现为非出血性神经功能缺损。栓塞为主要治疗(67%),总体临床结局较好,无死亡。
要点
- Cognard V型dAVF以非出血性神经功能缺损为主要表现,出血占14%。
- 栓塞为最常用初始治疗,完全闭塞率71%;显微手术88%,放射外科40%。
- 末次随访平均2.4年,69%患者mRS≤2,无死亡,永久并发症3%。
核心结论
- Cognard V型dAVF神经功能致残风险高,但及时的多模式干预可获得良好功能结局,并发症率低且多为暂时性,支持积极而个体化的治疗策略。
研究设计与样本
- CONDOR多中心登记回顾性分析,覆盖16家学术中心,纳入1077例dAVF患者中37例经血管造影确诊的Cognard V型病变(3%)。
- 记录人口学、影像特征、治疗策略、操作并发症及改良Rankin量表(mRS)评分。
主要发现
- 患者平均年龄57岁,59.5%为男性;68%以非出血性神经功能缺损起病,14%有出血。
- 最常见部位为枕骨大孔(32%)。
- 栓塞为67%病例的主要治疗,完全闭塞率71%;首选显微手术占22%(闭塞率88%),放射外科占14%(成功率40%);补救治疗进一步改善闭塞结局。
- 暂时性并发症8%(3/37):2例栓塞后暂时性神经功能缺损、1例术后暂时性脑积水;永久性并发症3%(1/37),为治疗相关出血。
- 末次随访平均2.4年,69%(24/35)维持或改善至mRS≤2,无死亡;29%(10/35)功能改善,40%(14/35)mRS下降且均与dAVF本身无关。
关键数值与推荐
- Cognard V型定义为脊髓髓周静脉引流的dAVF,占本组dAVF的3%(37/1077)。
- 栓塞后完全闭塞率71%,首选显微手术闭塞率88%,放射外科成功率40%。
- 暂时性并发症8%,永久性并发症3%,末次随访mRS≤2者占69%(24/35)。
临床怎么用
- 对Cognard V型dAVF应积极干预,可首选栓塞,必要时联合显微手术或放射外科及补救治疗。
- 治疗决策需个体化权衡,以预防永久性神经功能残疾为目标,并关注暂时性并发症的监测与处理。
局限性
- 为回顾性多中心登记分析,Cognard V型样本量小(37例),治疗分组非随机,随访时间平均2.4年。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cognard type V dural arteriovenous fistulas (dAVFs), defined by spinal perimedullary venous drainage, represent a rare and aggressive neurovascular pathology. Comprehensive multicenter data remain scarce. The authors present the largest multicenter analysis to date, characterizing presentation, radiology, treatment, complications, and functional outcomes of Cognard type V dAVFs. METHODS: The authors retrospectively analyzed patients with angiographically confirmed Cognard type V dAVFs from the Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR), spanning 16 academic centers. Patient demographics, imaging features, treatment strategies, procedural complications, and modified Rankin Scale (mRS) scores were recorded. RESULTS: Among 1077 patients with dAVFs, 37 (3%) had Cognard type V lesions. The mean patient age was 57 years, and 59.5% of patients were male. Most presented with nonhemorrhagic neurological deficits (68%), while 14% had hemorrhage. The most common location was the foramen magnum (32%). Embolization was the primary treatment in 67% of cases, complete obliteration was achieved in 71% of cases. Upfront microsurgery was performed in 22% of patients (obliteration rate 88%), and radiosurgery in 14% (success rate 40%). Salvage treatment further improved obliteration outcomes. Temporary complications occurred in 8% of patients (3/37): 2 with transient neurological deficits postembolization and 1 with transient hydrocephalus after surgery. Permanent complications were observed in 3% (1/37) due to treatment-related hemorrhage. At the last follow-up (mean 2.4 years), 69% (24/35) of patients maintained or improved to an mRS score ≤ 2. No deaths occurred. Functional improvement was seen in 29% (10/35), while mRS decline was in 40% of patients (14/35), all unrelated to the dAVF itself. CONCLUSIONS: Cognard type V dAVFs carry a high risk of neurological morbidity. However, favorable functional outcomes are achievable with timely, multimodal intervention. Complication rates remain low, with most being transient. These data support aggressive but tailored management to prevent permanent disability in this high-risk population.
引用
- Potgieser ARE, Hallak H, Connor M, et al. Intracranial dural arteriovenous fistulas with perimedullary venous drainage: analysis of the multinational CONDOR registry. J Neurosurg. 2026. PMID: 42566799. doi:10.3171/2026.2.JNS252734
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。